NIAID Banner Logo Image

Other Viruses Citation List: January 30 - February 12, 2015

Hepatitis B Virus

1. Hydroxylated Tropolones Inhibit Hepatitis B Virus Replication by Blocking Viral Ribonuclease H Activity. Lu, G., E. Lomonosova, X. Cheng, E.A. Moran, M.J. Meyers, S.F. Le Grice, C.J. Thomas, J.K. Jiang, C. Meck, D.R. Hirsch, M.P. D'Erasmo, D.M. Suyabatmaz, R.P. Murelli, and J.E. Tavis. Antimicrobial Agents and Chemotherapy, 2015. 59(2): p. 1070-1079. PMID[25451058].

[PubMed]. OV_0130-021215.


2. Alisporivir Inhibition of Hepatocyte Cyclophilins Reduces HBV Replication and Hepatitis B Surface Antigen Production. Phillips, S., S. Chokshi, U. Chatterji, A. Riva, M. Bobardt, R. Williams, P. Gallay, and N.V. Naoumov. Gastroenterology, 2015. 148(2): p. 403-414. PMID[25305505].

[PubMed]. OV_0130-021215.


3. STING Agonists Induce an Innate Antiviral Immune Response Against Hepatitis B Virus. Guo, F., Y. Han, X. Zhao, J. Wang, F. Liu, C. Xu, L. Wei, J.D. Jiang, T.M. Block, J.T. Guo, and J. Chang. Antimicrobial Agents and Chemotherapy, 2015. 59(2): p. 1273-1281. PMID[25512416].

[PubMed]. OV_0130-021215.


4. Sustained Inhibition of Hepatitis B Virus Replication in Vivo Using RNAi-activating Lentiviruses. Ivacik, D., A. Ely, N. Ferry, and P. Arbuthnot. Gene Therapy, 2015. 22(2): p. 163-171. PMID[25338920].

[PubMed]. OV_0130-021215.


5. Postexposure Prophylactic Effect of Hepatitis B Virus (HBV)-active Antiretroviral Therapy Against HBV Infection. Watanabe, T., S. Hamada-Tsutsumi, Y. Yokomaku, J. Imamura, W. Sugiura, and Y. Tanaka. Antimicrobial Agents and Chemotherapy, 2015. 59(2): p. 1292-1298. PMID[25512419].

[PubMed]. OV_0130-021215.

Hepatitis C Virus

6. Caffeine Inhibits Hepatitis C Virus Replication in Vitro. Batista, M.N., B.M. Carneiro, A.C. Braga, and P. Rahal. Archives of Virology, 2015. 160(2): p. 399-407. PMID[25491197].

[PubMed]. OV_0130-021215.


7. TnBP/Triton X-45 Treatment of Plasma for Transfusion Efficiently Inactivates Hepatitis C Virus. Chou, M.L., T. Burnouf, S.P. Chang, T.C. Hung, C.C. Lin, C.D. Richardson, and L.T. Lin. Plos One, 2015. 10(2): p. e0117800. PMID[25658612].

[PubMed]. OV_0130-021215.


8. The Inhibitory Effects of Anacardic Acid on Hepatitis C Virus Life Cycle. Hundt, J., Z. Li, and Q. Liu. Plos One, 2015. 10(2): p. e0117514. PMID[25658101].

[PubMed]. OV_0130-021215.


9. Synthesis of Novel 4'alpha-Trifluoromethyl-2'beta-C-methyl-carbodine Analogs as anti-Hepatitis C Virus Agents. Kim, S., E. Kim, and J.H. Hong. Nucleosides, Nucleotides and Nucleic Acids, 2015. 34(2): p. 79-91. PMID[25621702].

[PubMed]. OV_0130-021215.


10. In Vitro and in Vivo Antiviral Activity and Resistance Profile of Ombitasvir, an Inhibitor of Hepatitis C Virus NS5A. Krishnan, P., J. Beyer, N. Mistry, G. Koev, T. Reisch, D. DeGoey, W. Kati, A. Campbell, L. Williams, W. Xie, C. Setze, A. Molla, C. Collins, and T. Pilot-Matias. Antimicrobial Agents and Chemotherapy, 2015. 59(2): p. 979-987. PMID[25451055].

[PubMed]. OV_0130-021215.


11. In Vitro and in Vivo Antiviral Activity and Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor ABT-450. Pilot-Matias, T., R. Tripathi, D. Cohen, I. Gaultier, T. Dekhtyar, L. Lu, T. Reisch, M. Irvin, T. Hopkins, R. Pithawalla, T. Middleton, T. Ng, K. McDaniel, Y.S. Or, R. Menon, D. Kempf, A. Molla, and C. Collins. Antimicrobial Agents and Chemotherapy, 2015. 59(2): p. 988-997. PMID[25451053].

[PubMed]. OV_0130-021215.


12. Solid Lipid Nanoparticles as Non-viral Vector for the Treatment of Chronic Hepatitis C by RNA Interference. Torrecilla, J., A. Del Pozo-Rodriguez, P.S. Apaolaza, M.A. Solinis, and A. Rodriguez-Gascon. International Journal of Pharmaceutics, 2015. 479(1): p. 181-188. PMID[25542984].

[PubMed]. OV_0130-021215.


13. Novel Dengue Virus NS2B/NS3 Protease Inhibitors. Wu, H., S. Bock, M. Snitko, T. Berger, T. Weidner, S. Holloway, M. Kanitz, W.E. Diederich, H. Steuber, C. Walter, D. Hofmann, B. Weissbrich, R. Spannaus, E.G. Acosta, R. Bartenschlager, B. Engels, T. Schirmeister, and J. Bodem. Antimicrobial Agents and Chemotherapy, 2015. 59(2): p. 1100-1109. PMID[25487800].

[PubMed]. OV_0130-021215.


14. Inhibition of Hepatitis E Virus Replication by Proteasome Inhibitor Is Nonspecific. Xu, L., X. Zhou, M.P. Peppelenbosch, and Q. Pan. Archives of Virology, 2015. 160(2): p. 435-439. PMID[25476751].

[PubMed]. OV_0130-021215.

Feline Immunodeficiency Virus

15. Antiviral Treatment of Feline Immunodeficiency Virus-infected Cats with (R)-9-(2-Phosphonylmethoxypropyl)-2,6-diaminopurine. Taffin, E., D. Paepe, N. Goris, J. Auwerx, M. Debille, J. Neyts, I. Van de Maele, and S. Daminet. Journal of Feline Medicine and Surgery, 2015. 17(2): p. 79-86. PMID[24782459].

[PubMed]. OV_0130-021215.

Epstein-Barr Virus

16. Small Molecule Growth Inhibitors of Human Oncogenic Gammaherpesvirus Infected B-Cells. Dzeng, R.K., H.C. Jha, J. Lu, A. Saha, S. Banerjee, and E.S. Robertson. Molecular Oncology, 2015. 9(2): p. 365-376. PMID[25306391].

[PubMed]. OV_0130-021215.


17. Genipin as a Novel Chemical Activator of EBV Lytic Cycle. Son, M., M. Lee, E. Ryu, A. Moon, C.S. Jeong, Y.W. Jung, G.H. Park, G.H. Sung, H. Cho, and H. Kang. Journal of Microbiology, 2015. 53(2): p. 155-165. PMID[25626372].

[PubMed]. OV_0130-021215.

Human Cytomegalovirus

18. Anti-cytomegalovirus Activity of the Anthraquinone Atanyl Blue PRL. Alam, Z., Z. Al-Mahdi, Y. Zhu, Z. McKee, D.S. Parris, H.I. Parikh, G.E. Kellogg, A. Kuchta, and M.A. McVoy. Antiviral Research, 2015. 114: p. 86-95. PMID[25499125].

[PubMed]. OV_0130-021215.

Herpes Simplex Virus 1

19. Beta-Amyloid Peptides Display Protective Activity against the Human Alzheimer's Disease-associated Herpes Simplex Virus-1. Bourgade, K., H. Garneau, G. Giroux, A.Y. Le Page, C. Bocti, G. Dupuis, E.H. Frost, and T. Fulop, Jr. Biogerontology, 2015. 16(1): p. 85-98. PMID[25376108].

[PubMed]. OV_0130-021215.


20. Houttuynia cordata Targets the Beginning Stage of Herpes Simplex Virus Infection. Hung, P.Y., B.C. Ho, S.Y. Lee, S.Y. Chang, C.L. Kao, S.S. Lee, and C.N. Lee. Plos One, 2015. 10(2): p. e0115475. PMID[25643242].

[PubMed]. OV_0130-021215.


21. Total Synthesis and Antiviral Activity of Indolosesquiterpenoids from the Xiamycin and Oridamycin Families. Meng, Z., H. Yu, L. Li, W. Tao, H. Chen, M. Wan, P. Yang, D.J. Edmonds, J. Zhong, and A. Li. Nature Communications, 2015. 6(6096): 8pp. PMID[25648883].

[PubMed]. OV_0130-021215.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2024